LTGO

Latigo Biotherapeutics, Inc.

Healthcare · Biotechnology

$250.63 sample

+1.57 (+0.63%) 1D

Market cap

$1.41T

Price as of

2026-10-03

Latest filing

8-K

Alerts

8

Price$250.63 +14.89% 3M daily closessample

261.00214.01

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: EVP, Operations
Sep 17INSInsider buy: EVP, Operations
Sep 10INSInsider buy: EVP, Operations
Sep 03INSInsider buy: EVP, Operations
Aug 27INSInsider sell: Chief Executive Officer
Aug 21INSInsider sell: General Counsel
Aug 13INSInsider buy: 10% owner
Aug 07INSInsider buy: Chief Financial Officer

Sign up to see the real LTGO record →

Company facts

SEC EDGAR registration

Name: Latigo Biotherapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +51sample, -100 to +100
Reporting currency: USD

Who is positioning in LTGO

sample

Insiders: 30 insider transactions over 90 days, net selling, $600.1M
Congress: 5 members traded over 90 days
Institutions · 13F: 23 funds hold $15.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$58.6B +20.7% y/y

Q4 2024Q3 2026

Inventory$34.0B +17.3% y/y

Q4 2024Q3 2026

Accounts receivable$25.7B +15.1% y/y

Q4 2024Q3 2026

Total debt$68.4B +8.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $686.5B +4.1% 3M
Sample peer B: $1.14T +1.1% 3M
Sample peer C: $335.0B +8.2% 3M
Sample peer D: $806.5B +10.1% 3M
Sample peer E: $797.0B -9.1% 3M